0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metaxalone Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-13J3880
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Metaxalone Market Insights and Forecast to 2028
BUY CHAPTERS

Global Metaxalone Market Insights, Forecast to 2030

Code: QYRE-Auto-13J3880
Report
December 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Metaxalone Market

Metaxalone is a white, odourless crystalline powder used to relax muscles and relieve pain that could have occurred due to strain, sprain, and other musculoskeletal conditions. It has sedative and skeletal muscle relaxant effect on the body and helps relieve pain. The compound is freely soluble in chloroform; however insoluble in ether or water.
The global Metaxalone market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Metaxalone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Metaxalone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Metaxalone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Metaxalone include Biosynth, Chunghwa Chemical Synthesis and Biotech, Sigma-Aldrich, CDI Technology, Angelini, Pfizer, Aurum Pharmatech, Finetech Industry and Biocore, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Metaxalone, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Metaxalone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Metaxalone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Metaxalone sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Metaxalone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Metaxalone sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Metaxalone Market Report

Report Metric Details
Report Name Metaxalone Market
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sigma-Aldrich, CDI Technology, Angelini, Pfizer, Aurum Pharmatech, Finetech Industry, Biocore, Oxchem Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Metaxalone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Metaxalone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metaxalone sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Metaxalone Market report?

Ans: The main players in the Metaxalone Market are Sigma-Aldrich, CDI Technology, Angelini, Pfizer, Aurum Pharmatech, Finetech Industry, Biocore, Oxchem Corporation

What are the Application segmentation covered in the Metaxalone Market report?

Ans: The Applications covered in the Metaxalone Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Metaxalone Market report?

Ans: The Types covered in the Metaxalone Market report are Bone Pain, Muscle Pain, Joint Pain, Others

Recommended Reports

Pain Relief Markets

Pharmaceutical Ingredients

Therapy & Devices

1 Study Coverage
1.1 Metaxalone Product Introduction
1.2 Market by Type
1.2.1 Global Metaxalone Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Bone Pain
1.2.3 Muscle Pain
1.2.4 Joint Pain
1.2.5 Others
1.3 Market by Application
1.3.1 Global Metaxalone Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Metaxalone Sales Estimates and Forecasts 2019-2030
2.2 Global Metaxalone Revenue by Region
2.2.1 Global Metaxalone Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Metaxalone Revenue by Region (2019-2024)
2.2.3 Global Metaxalone Revenue by Region (2025-2030)
2.2.4 Global Metaxalone Revenue Market Share by Region (2019-2030)
2.3 Global Metaxalone Sales Estimates and Forecasts 2019-2030
2.4 Global Metaxalone Sales by Region
2.4.1 Global Metaxalone Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Metaxalone Sales by Region (2019-2024)
2.4.3 Global Metaxalone Sales by Region (2025-2030)
2.4.4 Global Metaxalone Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Metaxalone Sales by Manufacturers
3.1.1 Global Metaxalone Sales by Manufacturers (2019-2024)
3.1.2 Global Metaxalone Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metaxalone in 2023
3.2 Global Metaxalone Revenue by Manufacturers
3.2.1 Global Metaxalone Revenue by Manufacturers (2019-2024)
3.2.2 Global Metaxalone Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Metaxalone Revenue in 2023
3.3 Global Key Players of Metaxalone, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Metaxalone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Metaxalone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Metaxalone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Metaxalone, Product Offered and Application
3.8 Global Key Manufacturers of Metaxalone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Metaxalone Sales by Type
4.1.1 Global Metaxalone Historical Sales by Type (2019-2024)
4.1.2 Global Metaxalone Forecasted Sales by Type (2025-2030)
4.1.3 Global Metaxalone Sales Market Share by Type (2019-2030)
4.2 Global Metaxalone Revenue by Type
4.2.1 Global Metaxalone Historical Revenue by Type (2019-2024)
4.2.2 Global Metaxalone Forecasted Revenue by Type (2025-2030)
4.2.3 Global Metaxalone Revenue Market Share by Type (2019-2030)
4.3 Global Metaxalone Price by Type
4.3.1 Global Metaxalone Price by Type (2019-2024)
4.3.2 Global Metaxalone Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Metaxalone Sales by Application
5.1.1 Global Metaxalone Historical Sales by Application (2019-2024)
5.1.2 Global Metaxalone Forecasted Sales by Application (2025-2030)
5.1.3 Global Metaxalone Sales Market Share by Application (2019-2030)
5.2 Global Metaxalone Revenue by Application
5.2.1 Global Metaxalone Historical Revenue by Application (2019-2024)
5.2.2 Global Metaxalone Forecasted Revenue by Application (2025-2030)
5.2.3 Global Metaxalone Revenue Market Share by Application (2019-2030)
5.3 Global Metaxalone Price by Application
5.3.1 Global Metaxalone Price by Application (2019-2024)
5.3.2 Global Metaxalone Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Metaxalone Market Size by Type
6.1.1 US & Canada Metaxalone Sales by Type (2019-2030)
6.1.2 US & Canada Metaxalone Revenue by Type (2019-2030)
6.2 US & Canada Metaxalone Market Size by Application
6.2.1 US & Canada Metaxalone Sales by Application (2019-2030)
6.2.2 US & Canada Metaxalone Revenue by Application (2019-2030)
6.3 US & Canada Metaxalone Market Size by Country
6.3.1 US & Canada Metaxalone Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Metaxalone Sales by Country (2019-2030)
6.3.3 US & Canada Metaxalone Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Metaxalone Market Size by Type
7.1.1 Europe Metaxalone Sales by Type (2019-2030)
7.1.2 Europe Metaxalone Revenue by Type (2019-2030)
7.2 Europe Metaxalone Market Size by Application
7.2.1 Europe Metaxalone Sales by Application (2019-2030)
7.2.2 Europe Metaxalone Revenue by Application (2019-2030)
7.3 Europe Metaxalone Market Size by Country
7.3.1 Europe Metaxalone Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Metaxalone Sales by Country (2019-2030)
7.3.3 Europe Metaxalone Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Metaxalone Market Size
8.1.1 China Metaxalone Sales (2019-2030)
8.1.2 China Metaxalone Revenue (2019-2030)
8.2 China Metaxalone Market Size by Application
8.2.1 China Metaxalone Sales by Application (2019-2030)
8.2.2 China Metaxalone Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Metaxalone Market Size by Type
9.1.1 Asia Metaxalone Sales by Type (2019-2030)
9.1.2 Asia Metaxalone Revenue by Type (2019-2030)
9.2 Asia Metaxalone Market Size by Application
9.2.1 Asia Metaxalone Sales by Application (2019-2030)
9.2.2 Asia Metaxalone Revenue by Application (2019-2030)
9.3 Asia Metaxalone Sales by Region
9.3.1 Asia Metaxalone Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Metaxalone Revenue by Region (2019-2030)
9.3.3 Asia Metaxalone Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Metaxalone Market Size by Type
10.1.1 Middle East, Africa and Latin America Metaxalone Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Metaxalone Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Metaxalone Market Size by Application
10.2.1 Middle East, Africa and Latin America Metaxalone Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Metaxalone Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Metaxalone Sales by Country
10.3.1 Middle East, Africa and Latin America Metaxalone Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Metaxalone Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Metaxalone Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Biosynth
11.1.1 Biosynth Company Information
11.1.2 Biosynth Overview
11.1.3 Biosynth Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Biosynth Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biosynth Recent Developments
11.2 Chunghwa Chemical Synthesis and Biotech
11.2.1 Chunghwa Chemical Synthesis and Biotech Company Information
11.2.2 Chunghwa Chemical Synthesis and Biotech Overview
11.2.3 Chunghwa Chemical Synthesis and Biotech Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Chunghwa Chemical Synthesis and Biotech Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chunghwa Chemical Synthesis and Biotech Recent Developments
11.3 Sigma-Aldrich
11.3.1 Sigma-Aldrich Company Information
11.3.2 Sigma-Aldrich Overview
11.3.3 Sigma-Aldrich Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sigma-Aldrich Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sigma-Aldrich Recent Developments
11.4 CDI Technology
11.4.1 CDI Technology Company Information
11.4.2 CDI Technology Overview
11.4.3 CDI Technology Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 CDI Technology Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CDI Technology Recent Developments
11.5 Angelini
11.5.1 Angelini Company Information
11.5.2 Angelini Overview
11.5.3 Angelini Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Angelini Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Angelini Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Pfizer Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Aurum Pharmatech
11.7.1 Aurum Pharmatech Company Information
11.7.2 Aurum Pharmatech Overview
11.7.3 Aurum Pharmatech Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Aurum Pharmatech Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurum Pharmatech Recent Developments
11.8 Finetech Industry
11.8.1 Finetech Industry Company Information
11.8.2 Finetech Industry Overview
11.8.3 Finetech Industry Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Finetech Industry Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Finetech Industry Recent Developments
11.9 Biocore
11.9.1 Biocore Company Information
11.9.2 Biocore Overview
11.9.3 Biocore Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Biocore Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biocore Recent Developments
11.10 Oxchem Corporation
11.10.1 Oxchem Corporation Company Information
11.10.2 Oxchem Corporation Overview
11.10.3 Oxchem Corporation Metaxalone Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Oxchem Corporation Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Oxchem Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Metaxalone Industry Chain Analysis
12.2 Metaxalone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metaxalone Production Mode & Process
12.4 Metaxalone Sales and Marketing
12.4.1 Metaxalone Sales Channels
12.4.2 Metaxalone Distributors
12.5 Metaxalone Customers
13 Market Dynamics
13.1 Metaxalone Industry Trends
13.2 Metaxalone Market Drivers
13.3 Metaxalone Market Challenges
13.4 Metaxalone Market Restraints
14 Key Findings in The Global Metaxalone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Metaxalone Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Bone Pain
    Table 3. Major Manufacturers of Muscle Pain
    Table 4. Major Manufacturers of Joint Pain
    Table 5. Major Manufacturers of Others
    Table 6. Global Metaxalone Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Metaxalone Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Metaxalone Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Metaxalone Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Metaxalone Revenue Market Share by Region (2019-2024)
    Table 11. Global Metaxalone Revenue Market Share by Region (2025-2030)
    Table 12. Global Metaxalone Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Metaxalone Sales by Region (2019-2024) & (K Piece)
    Table 14. Global Metaxalone Sales by Region (2025-2030) & (K Piece)
    Table 15. Global Metaxalone Sales Market Share by Region (2019-2024)
    Table 16. Global Metaxalone Sales Market Share by Region (2025-2030)
    Table 17. Global Metaxalone Sales by Manufacturers (2019-2024) & (K Piece)
    Table 18. Global Metaxalone Sales Share by Manufacturers (2019-2024)
    Table 19. Global Metaxalone Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Metaxalone Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Metaxalone, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Metaxalone Price by Manufacturers 2019-2024 (USD/Piece)
    Table 23. Global Metaxalone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Metaxalone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metaxalone as of 2023)
    Table 25. Global Key Manufacturers of Metaxalone, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Metaxalone, Product Offered and Application
    Table 27. Global Key Manufacturers of Metaxalone, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Metaxalone Sales by Type (2019-2024) & (K Piece)
    Table 30. Global Metaxalone Sales by Type (2025-2030) & (K Piece)
    Table 31. Global Metaxalone Sales Share by Type (2019-2024)
    Table 32. Global Metaxalone Sales Share by Type (2025-2030)
    Table 33. Global Metaxalone Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Metaxalone Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Metaxalone Revenue Share by Type (2019-2024)
    Table 36. Global Metaxalone Revenue Share by Type (2025-2030)
    Table 37. Metaxalone Price by Type (2019-2024) & (USD/Piece)
    Table 38. Global Metaxalone Price Forecast by Type (2025-2030) & (USD/Piece)
    Table 39. Global Metaxalone Sales by Application (2019-2024) & (K Piece)
    Table 40. Global Metaxalone Sales by Application (2025-2030) & (K Piece)
    Table 41. Global Metaxalone Sales Share by Application (2019-2024)
    Table 42. Global Metaxalone Sales Share by Application (2025-2030)
    Table 43. Global Metaxalone Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Metaxalone Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Metaxalone Revenue Share by Application (2019-2024)
    Table 46. Global Metaxalone Revenue Share by Application (2025-2030)
    Table 47. Metaxalone Price by Application (2019-2024) & (USD/Piece)
    Table 48. Global Metaxalone Price Forecast by Application (2025-2030) & (USD/Piece)
    Table 49. US & Canada Metaxalone Sales by Type (2019-2024) & (K Piece)
    Table 50. US & Canada Metaxalone Sales by Type (2025-2030) & (K Piece)
    Table 51. US & Canada Metaxalone Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Metaxalone Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Metaxalone Sales by Application (2019-2024) & (K Piece)
    Table 54. US & Canada Metaxalone Sales by Application (2025-2030) & (K Piece)
    Table 55. US & Canada Metaxalone Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Metaxalone Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Metaxalone Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Metaxalone Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Metaxalone Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Metaxalone Sales by Country (2019-2024) & (K Piece)
    Table 61. US & Canada Metaxalone Sales by Country (2025-2030) & (K Piece)
    Table 62. Europe Metaxalone Sales by Type (2019-2024) & (K Piece)
    Table 63. Europe Metaxalone Sales by Type (2025-2030) & (K Piece)
    Table 64. Europe Metaxalone Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Metaxalone Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Metaxalone Sales by Application (2019-2024) & (K Piece)
    Table 67. Europe Metaxalone Sales by Application (2025-2030) & (K Piece)
    Table 68. Europe Metaxalone Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Metaxalone Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Metaxalone Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Metaxalone Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Metaxalone Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Metaxalone Sales by Country (2019-2024) & (K Piece)
    Table 74. Europe Metaxalone Sales by Country (2025-2030) & (K Piece)
    Table 75. China Metaxalone Sales by Type (2019-2024) & (K Piece)
    Table 76. China Metaxalone Sales by Type (2025-2030) & (K Piece)
    Table 77. China Metaxalone Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Metaxalone Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Metaxalone Sales by Application (2019-2024) & (K Piece)
    Table 80. China Metaxalone Sales by Application (2025-2030) & (K Piece)
    Table 81. China Metaxalone Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Metaxalone Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Metaxalone Sales by Type (2019-2024) & (K Piece)
    Table 84. Asia Metaxalone Sales by Type (2025-2030) & (K Piece)
    Table 85. Asia Metaxalone Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Metaxalone Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Metaxalone Sales by Application (2019-2024) & (K Piece)
    Table 88. Asia Metaxalone Sales by Application (2025-2030) & (K Piece)
    Table 89. Asia Metaxalone Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Metaxalone Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Metaxalone Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Metaxalone Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Metaxalone Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Metaxalone Sales by Region (2019-2024) & (K Piece)
    Table 95. Asia Metaxalone Sales by Region (2025-2030) & (K Piece)
    Table 96. Middle East, Africa and Latin America Metaxalone Sales by Type (2019-2024) & (K Piece)
    Table 97. Middle East, Africa and Latin America Metaxalone Sales by Type (2025-2030) & (K Piece)
    Table 98. Middle East, Africa and Latin America Metaxalone Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Metaxalone Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Metaxalone Sales by Application (2019-2024) & (K Piece)
    Table 101. Middle East, Africa and Latin America Metaxalone Sales by Application (2025-2030) & (K Piece)
    Table 102. Middle East, Africa and Latin America Metaxalone Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Metaxalone Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Metaxalone Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Metaxalone Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Metaxalone Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Metaxalone Sales by Country (2019-2024) & (K Piece)
    Table 108. Middle East, Africa and Latin America Metaxalone Sales by Country (2025-2030) & (K Piece)
    Table 109. Biosynth Company Information
    Table 110. Biosynth Description and Major Businesses
    Table 111. Biosynth Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 112. Biosynth Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Biosynth Recent Developments
    Table 114. Chunghwa Chemical Synthesis and Biotech Company Information
    Table 115. Chunghwa Chemical Synthesis and Biotech Description and Major Businesses
    Table 116. Chunghwa Chemical Synthesis and Biotech Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 117. Chunghwa Chemical Synthesis and Biotech Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Chunghwa Chemical Synthesis and Biotech Recent Developments
    Table 119. Sigma-Aldrich Company Information
    Table 120. Sigma-Aldrich Description and Major Businesses
    Table 121. Sigma-Aldrich Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 122. Sigma-Aldrich Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Sigma-Aldrich Recent Developments
    Table 124. CDI Technology Company Information
    Table 125. CDI Technology Description and Major Businesses
    Table 126. CDI Technology Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 127. CDI Technology Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. CDI Technology Recent Developments
    Table 129. Angelini Company Information
    Table 130. Angelini Description and Major Businesses
    Table 131. Angelini Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 132. Angelini Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Angelini Recent Developments
    Table 134. Pfizer Company Information
    Table 135. Pfizer Description and Major Businesses
    Table 136. Pfizer Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 137. Pfizer Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Pfizer Recent Developments
    Table 139. Aurum Pharmatech Company Information
    Table 140. Aurum Pharmatech Description and Major Businesses
    Table 141. Aurum Pharmatech Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 142. Aurum Pharmatech Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Aurum Pharmatech Recent Developments
    Table 144. Finetech Industry Company Information
    Table 145. Finetech Industry Description and Major Businesses
    Table 146. Finetech Industry Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 147. Finetech Industry Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Finetech Industry Recent Developments
    Table 149. Biocore Company Information
    Table 150. Biocore Description and Major Businesses
    Table 151. Biocore Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 152. Biocore Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Biocore Recent Developments
    Table 154. Oxchem Corporation Company Information
    Table 155. Oxchem Corporation Description and Major Businesses
    Table 156. Oxchem Corporation Metaxalone Sales (K Piece), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
    Table 157. Oxchem Corporation Metaxalone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Oxchem Corporation Recent Developments
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Metaxalone Distributors List
    Table 162. Metaxalone Customers List
    Table 163. Metaxalone Market Trends
    Table 164. Metaxalone Market Drivers
    Table 165. Metaxalone Market Challenges
    Table 166. Metaxalone Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Metaxalone Product Picture
    Figure 2. Global Metaxalone Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Metaxalone Market Share by Type in 2023 & 2030
    Figure 4. Bone Pain Product Picture
    Figure 5. Muscle Pain Product Picture
    Figure 6. Joint Pain Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Metaxalone Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Metaxalone Market Share by Application in 2023 & 2030
    Figure 10. Hospitals
    Figure 11. Clinics
    Figure 12. Others
    Figure 13. Metaxalone Report Years Considered
    Figure 14. Global Metaxalone Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Metaxalone Revenue 2019-2030 (US$ Million)
    Figure 16. Global Metaxalone Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Metaxalone Revenue Market Share by Region (2019-2030)
    Figure 18. Global Metaxalone Sales 2019-2030 ((K Piece)
    Figure 19. Global Metaxalone Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Metaxalone Sales YoY (2019-2030) & (K Piece)
    Figure 21. US & Canada Metaxalone Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Metaxalone Sales YoY (2019-2030) & (K Piece)
    Figure 23. Europe Metaxalone Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Metaxalone Sales YoY (2019-2030) & (K Piece)
    Figure 25. China Metaxalone Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Metaxalone Sales YoY (2019-2030) & (K Piece)
    Figure 27. Asia (excluding China) Metaxalone Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Metaxalone Sales YoY (2019-2030) & (K Piece)
    Figure 29. Middle East, Africa and Latin America Metaxalone Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Metaxalone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Metaxalone in the World: Market Share by Metaxalone Revenue in 2023
    Figure 32. Global Metaxalone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Metaxalone Sales Market Share by Type (2019-2030)
    Figure 34. Global Metaxalone Revenue Market Share by Type (2019-2030)
    Figure 35. Global Metaxalone Sales Market Share by Application (2019-2030)
    Figure 36. Global Metaxalone Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Metaxalone Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Metaxalone Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Metaxalone Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Metaxalone Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Metaxalone Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Metaxalone Sales Share by Country (2019-2030)
    Figure 43. U.S. Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Metaxalone Sales Market Share by Type (2019-2030)
    Figure 46. Europe Metaxalone Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Metaxalone Sales Market Share by Application (2019-2030)
    Figure 48. Europe Metaxalone Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Metaxalone Revenue Share by Country (2019-2030)
    Figure 50. Europe Metaxalone Sales Share by Country (2019-2030)
    Figure 51. Germany Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 52. France Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 56. China Metaxalone Sales Market Share by Type (2019-2030)
    Figure 57. China Metaxalone Revenue Market Share by Type (2019-2030)
    Figure 58. China Metaxalone Sales Market Share by Application (2019-2030)
    Figure 59. China Metaxalone Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Metaxalone Sales Market Share by Type (2019-2030)
    Figure 61. Asia Metaxalone Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Metaxalone Sales Market Share by Application (2019-2030)
    Figure 63. Asia Metaxalone Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Metaxalone Revenue Share by Region (2019-2030)
    Figure 65. Asia Metaxalone Sales Share by Region (2019-2030)
    Figure 66. Japan Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 70. India Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Metaxalone Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Metaxalone Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Metaxalone Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Metaxalone Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Metaxalone Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Metaxalone Sales Share by Country (2019-2030)
    Figure 77. Brazil Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Metaxalone Revenue (2019-2030) & (US$ Million)
    Figure 82. Metaxalone Value Chain
    Figure 83. Metaxalone Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture